APO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolution
Product quality
Read the official notice →- Date
- 2026-02-16
- Country
- Canada
- Product
- APO-CANDESARTAN
- Classification
- Type II
- Category
- Drugs & medical
- Source
- Health Canada
Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.
Other drugs & medical recalls in Canada
- 2026-02-18
CA- CA
- 2026-02-17
- CA
- 2026-02-13
- CA
- 2026-02-11
- CA
- CA